22196 Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices 

Arkansas for Medical Sciences, 

University of North Carolina at Chapel 

Hill, University of Minnesota, 

University of Wisconsin-Madison, 

Vanderbilt University, and Washington 

University in St. Louis. Four sites 

received funding to carry out 

Component A, which focuses on 

surveillance of ASD and either cerebral 

palsy or intellectual disability among 8- 

year-olds. Six sites received funding to 

carry out both Component A as well as 

Component B, which focuses on 

surveillance of ASD among 4-year-olds. 

In addition to the sites funded under the 

cooperative agreement, CDC also 

administers a site in Atlanta, Georgia, 

commonly known as the Metropolitan 

Atlanta Developmental Disabilities 

Surveillance Program (MADDSP). CDC requests OMB approval to collect 

performance monitoring and program 

evaluation information from all sites 

participating in the Autism and 

Developmental Disabilities Monitoring 

Network (including the site 

administered by CDC). Over the course 

of the four-year funding cycle, each site 

will submit a Checklist, Worksheets, 

and Performance Measures every six 

month and two-year intervals. The 

Checklist, Worksheets, and Performance 

Measures will be submitted to CDC by 

completing a Microsoft Excel-based data 

collection tool and uploading the 

information to a secure, passwordprotected FTP site. By developing a 

user-friendly data collection tool in 

Microsoft Excel, CDC anticipates that 

the reporting and tracking burden for 

awardees will be reduced due to: (1) 

awardees’ familiarity with the software, 

which reduces training burden; and (2) 

the compatibility of the templates with 

other record keeping processes that are 

already in place for many awardees. 

CDC staff and contractors will be 

responsible for converting each 

awardee’s submissions into a secure 

Microsoft Access-based system for 

reporting and analysis. CDC anticipates 

that respondent burden will be slightly 

higher at the initial six-month 

submission and will also be slightly 

higher for sites completing Component 

A&B compared to just Component A. 

The information to be collected will 

help CDC and awardees assure 

compliance with cooperative agreement 

requirements, support program 

evaluation efforts, and obtain 

information needed to respond to 

inquiries about program activities and 

program impact from Congress and 

other stakeholders. 

OMB approval is requested for three 

years. Participation is required as a 

condition of cooperative agreement 

funding. There are no costs to 

respondents other than their time. The 

total estimated burden hours are 125. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Component A only (initial six-month 

submission).

Checklist ........................................... 5 1 3/60 1 

Worksheets ...................................... 5 1 1.5 8 

Performance Measures .................... 5 1 30/60 3 

Component A&B (initial six-month 

submission).

Checklist ........................................... 6 1 3/60 1 

Worksheets ...................................... 6 1 2 12 

Performance Measures .................... 6 1 4/60 4 

Component A only (subsequent sixmonth and two-year submissions).Checklist ........................................... 5 5 3/60 1 

Worksheets ...................................... 5 5 1 25 

Performance Measures .................... 5 5 18/60 8 

Component A&B (subsequent sixmonth and two-year submissions).Checklist ........................................... 6 5 3/60 2 

Worksheets ...................................... 6 5 1.5 45 

Performance Measures .................... 6 5 30/60 15 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–09087 Filed 4–20–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Effectiveness of Teen 

Pregnancy Prevention Program Designed 

specifically for Young Males, DP15–007, 

initial review. 

SUMMARY: This document corrects a 

notice that was published in the Federal 

Register on April 14, 2015 Volume 80, 

Number 71, pages 19989. The title of the 

Special Emphasis Panel should read as 

above and time and date should read as 

follows: 

TIME AND DATE: 9:00 a.m.–6:00 p.m., 

April 7–8, 2015 (Closed). 

FOR FURTHER INFORMATION CONTACT: M. 

Chris Langub, Ph.D., Scientific Review 

Officer, CDC, 4770 Buford Highway NE., 

Mailstop F46, Atlanta, Georgia 30341, 

Telephone: (770) 488–3585, EEO6@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–09083 Filed 4–20–15; 8:45 am] 

BILLING CODE 4163–18–P 


tkelley on DSK3SPTVN1PROD with NOTICES